assay,std_type,SMILES,std_value,std_units,standard_relation,molecule_chembl_id,activity_type
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CCC(C1)C(C)(C)C2NS(=O)(=O)c1ccc(F)cc1,5000.0,nM,=,CHEMBL311039,active
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1cccs1,2700.0,nM,=,CHEMBL450926,active
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(F)cc1,1800.0,nM,=,CHEMBL310242,active
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Cl)cc1,11000.0,nM,=,CHEMBL74874,inactive
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Br)cc1,10000.0,nM,=,CHEMBL75183,active
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,305000.0,nM,=,CHEMBL563,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(Cl)c(Cl)c2)c(F)c1,75000.0,nM,=,CHEMBL196279,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,77000.0,nM,=,CHEMBL195970,inactive
Concentration required to inhibit A beta 40 peptide,IC50,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,94000.0,nM,=,CHEMBL195970,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,21000.0,nM,=,CHEMBL264006,inactive
Concentration required to inhibit A beta 40 peptide,IC50,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,46000.0,nM,=,CHEMBL264006,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,129000.0,nM,=,CHEMBL193971,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2csc3ccccc23)c(F)c1,83000.0,nM,=,CHEMBL194274,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,COc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,67000.0,nM,=,CHEMBL196321,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc3c(c2)OCO3)c(F)c1,210000.0,nM,=,CHEMBL196322,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(OC3CCCCC3)cc2)c(F)c1,41000.0,nM,=,CHEMBL380778,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(-c3ccc(O)cc3)cc2)c(F)c1,35000.0,nM,=,CHEMBL197202,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,111000.0,nM,=,CHEMBL196246,inactive
Concentration required to inhibit A beta 40 peptide 100 um,IC50,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,22000.0,nM,=,CHEMBL196246,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,41000.0,nM,=,CHEMBL196945,inactive
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,14000.0,nM,=,CHEMBL196945,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,96300.0,nM,=,CHEMBL196946,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,46000.0,nM,=,CHEMBL372751,inactive
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,101000.0,nM,=,CHEMBL372751,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C)(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,70600.0,nM,=,CHEMBL194692,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,31600.0,nM,=,CHEMBL196947,inactive
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,409000.0,nM,=,CHEMBL196947,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,33600.0,nM,=,CHEMBL372846,inactive
Concentration required to inhibit A beta 40 peptide,IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,111000.0,nM,=,CHEMBL372846,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(F)cc4)c(F)c3)c(F)c2)CC1,57900.0,nM,=,CHEMBL427548,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC1(C)CC(Oc2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC(C)(C)C1,11000.0,nM,=,CHEMBL197140,inactive
Concentration required to inhibit A beta 40 peptide,IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,81000.0,nM,=,CHEMBL382721,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCC(C(F)(F)F)CC4)cc3)c(F)c2)CC1,17700.0,nM,=,CHEMBL436483,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1nnn[nH]1,114000.0,nM,=,CHEMBL196070,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,64000.0,nM,=,CHEMBL193900,inactive
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,12000.0,nM,=,CHEMBL193900,inactive
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC(C(=O)OC(C)(C)C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,20000.0,nM,=,CHEMBL194020,inactive
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,280000.0,nM,=,CHEMBL190083,inactive
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,5.2,nM,=,CHEMBL199946,active
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,6000.0,nM,=,CHEMBL202877,active
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,9900.0,nM,=,CHEMBL200014,active
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,740.0,nM,=,CHEMBL202507,active
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,180.0,nM,=,CHEMBL200077,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,200.0,nM,=,CHEMBL204357,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2ccccc2)C1=O,6800.0,nM,=,CHEMBL206766,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NC/C=C/Cc1ccccc1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000.0,nM,=,CHEMBL204443,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NC1CCCC1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,6000.0,nM,=,CHEMBL381336,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NCc1ccco1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000.0,nM,=,CHEMBL205400,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCCCNC(=O)[C@@H](CCC)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,5000.0,nM,=,CHEMBL205714,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(NN3CCCCC3)c2)C1=O,74.0,nM,=,CHEMBL208230,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(C(F)(F)F)cc3)c2)C1=O,30.0,nM,=,CHEMBL424684,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(OC)cc3)c2)C1=O,160.0,nM,=,CHEMBL274414,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(F)c(Cl)c3)c2)C1=O,17.0,nM,=,CHEMBL208504,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc4c(c3)OCO4)c2)C1=O,152.0,nM,=,CHEMBL205970,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(OC)c3)c2)C1=O,54.0,nM,=,CHEMBL410532,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(C)c3)c2)C1=O,17.0,nM,=,CHEMBL208350,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3Cl)c2)C1=O,29.0,nM,=,CHEMBL382880,active
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3)c2)C1=O,15.0,nM,=,CHEMBL205907,active
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,530.0,nM,=,CHEMBL231446,active
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CCC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,16.0,nM,=,CHEMBL396543,active
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,180.0,nM,=,CHEMBL231548,active
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,140.0,nM,=,CHEMBL231547,active
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,120.0,nM,=,CHEMBL231449,active
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,540.0,nM,=,CHEMBL231448,active
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OC[C@H]2CC[C@@H](c3ccccc3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1,450.0,nM,=,CHEMBL396542,active
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,650.0,nM,=,CHEMBL231351,active
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,600.0,nM,=,CHEMBL395313,active
Inhibition of gamma-secretase,IC50,O=C(OCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,73.0,nM,=,CHEMBL231250,active
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,60.0,nM,=,CHEMBL231248,active
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,360.0,nM,=,CHEMBL395312,active
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,190.0,nM,=,CHEMBL390889,active
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,900.0,nM,=,CHEMBL231647,active
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,180.0,nM,=,CHEMBL231545,active
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,1000.0,nM,=,CHEMBL231035,active
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,680.0,nM,=,CHEMBL230931,active
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,880.0,nM,=,CHEMBL425304,active
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OCCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,780.0,nM,=,CHEMBL231125,active
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,1900.0,nM,=,CHEMBL390478,active
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,86.0,nM,=,CHEMBL231544,active
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,280.0,nM,=,CHEMBL389549,active
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,220.0,nM,=,CHEMBL231447,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,0.3,nM,=,CHEMBL240055,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,56.0,nM,=,CHEMBL240286,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,47.0,nM,=,CHEMBL240285,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,46.0,nM,=,CHEMBL398395,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,17.0,nM,=,CHEMBL240284,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,14.0,nM,=,CHEMBL240071,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12.0,nM,=,CHEMBL240070,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,27.0,nM,=,CHEMBL240069,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,3.5,nM,=,CHEMBL442801,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,=,CHEMBL239859,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,2.5,nM,=,CHEMBL239858,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,2.8,nM,=,CHEMBL400420,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,2.4,nM,=,CHEMBL239629,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,12.0,nM,=,CHEMBL393941,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,16.0,nM,=,CHEMBL236192,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,29.0,nM,=,CHEMBL429448,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,81.0,nM,=,CHEMBL236191,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,6.9,nM,=,CHEMBL236190,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,27.0,nM,=,CHEMBL236189,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,9.6,nM,=,CHEMBL236188,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,16.0,nM,=,CHEMBL236187,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)cc1,25.0,nM,=,CHEMBL236186,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,10.0,nM,=,CHEMBL236185,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,=,CHEMBL392060,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,6.9,nM,=,CHEMBL236184,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,17.0,nM,=,CHEMBL236183,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12.0,nM,=,CHEMBL392059,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,13.0,nM,=,CHEMBL236182,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,9.0,nM,=,CHEMBL394132,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,28.0,nM,=,CHEMBL238271,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.2,nM,=,CHEMBL392144,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC1(O)CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,104.0,nM,=,CHEMBL236196,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,57.0,nM,=,CHEMBL429449,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(O[C@@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,2425.0,nM,=,CHEMBL236195,active
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(O[C@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,15.0,nM,=,CHEMBL236193,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,4.3,nM,=,CHEMBL392144,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,39.0,nM,=,CHEMBL393941,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,32.0,nM,=,CHEMBL236192,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,144.0,nM,=,CHEMBL429448,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,45.0,nM,=,CHEMBL236190,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,20.0,nM,=,CHEMBL236188,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,115.0,nM,=,CHEMBL236187,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,25.0,nM,=,CHEMBL236185,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,7.7,nM,=,CHEMBL392060,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,8.3,nM,=,CHEMBL236184,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,15.0,nM,=,CHEMBL236183,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,14.0,nM,=,CHEMBL392059,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,10.0,nM,=,CHEMBL236182,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,20.0,nM,=,CHEMBL394132,active
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,190.0,nM,=,CHEMBL238271,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)n2)cc1N,600.0,nM,=,CHEMBL392878,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000.0,nM,=,CHEMBL418455,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc2cc3ccc(N(C)C)cc3nc2c1,600.0,nM,=,CHEMBL81880,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL116438,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)c2)ccc1O,100.0,nM,=,CHEMBL245688,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cc(Br)cc(/C=C/c3ccc(OC)c(OC)c3)c2)cc1OC,20000.0,nM,=,CHEMBL245476,inactive
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,1800.0,nM,=,CHEMBL396917,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)c2)ccc1O,2700.0,nM,=,CHEMBL248338,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)c2)cc1N(C)C,1100.0,nM,=,CHEMBL248337,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)c2)ccc1OC,1300.0,nM,=,CHEMBL248133,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)c2)cc1N,300.0,nM,=,CHEMBL248132,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,700.0,nM,=,CHEMBL248131,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000.0,nM,=,CHEMBL247932,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)c2)cc1OC,600.0,nM,=,CHEMBL247931,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,600.0,nM,=,CHEMBL247930,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(N(C)C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1900.0,nM,=,CHEMBL247728,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1400.0,nM,=,CHEMBL247727,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2ccc(O)c(OC)c2)nc(/C=C/c2ccc(O)c(OC)c2)c1,1700.0,nM,=,CHEMBL247726,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Cl)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100.0,nM,=,CHEMBL247530,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100.0,nM,=,CHEMBL427878,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,800.0,nM,=,CHEMBL247328,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,1100.0,nM,=,CHEMBL247929,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)n2)cc1O,900.0,nM,=,CHEMBL247927,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)n2)ccc1N(C)C,800.0,nM,=,CHEMBL391205,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(O)c3)n2)cc1O,900.0,nM,=,CHEMBL247725,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)n2)cc1OC,500.0,nM,=,CHEMBL247674,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,700.0,nM,=,CHEMBL247524,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)n2)ccc1O,2300.0,nM,=,CHEMBL427877,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)n2)cc1N(C)C,900.0,nM,=,CHEMBL394713,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(NC)c3)n2)ccc1O,500.0,nM,=,CHEMBL248327,active
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)n2)ccc1OC,1100.0,nM,=,CHEMBL248122,active
Inhibition of self-induced amyloid beta (1-40) aggregation by thioflavin T formation assay,IC50,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,9690.0,nM,=,CHEMBL450553,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccccc3o2)cc1,2300.0,nM,=,CHEMBL492216,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,810.0,nM,=,CHEMBL492217,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,160.0,nM,=,CHEMBL491203,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,130.0,nM,=,CHEMBL509088,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(F)ccc3o2)cc1,1980.0,nM,=,CHEMBL489978,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(Cl)ccc3o2)cc1,200.0,nM,=,CHEMBL446870,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(Br)ccc3o2)cc1,470.0,nM,=,CHEMBL489979,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(I)ccc3o2)cc1,170.0,nM,=,CHEMBL524114,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,70.0,nM,=,CHEMBL524141,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(O)cc3o2)cc1,3620.0,nM,=,CHEMBL443097,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,3440.0,nM,=,CHEMBL491406,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(F)cc3o2)cc1,2190.0,nM,=,CHEMBL491407,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(Cl)cc3o2)cc1,3210.0,nM,=,CHEMBL490798,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(Br)cc3o2)cc1,1340.0,nM,=,CHEMBL490799,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(I)cc3o2)cc1,2800.0,nM,=,CHEMBL492023,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N)cc3)cc2c1,820.0,nM,=,CHEMBL492024,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3cc(OC)ccc3o2)cc1,80.0,nM,=,CHEMBL523824,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cl.Nc1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,2950.0,nM,=,CHEMBL444393,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1.Cl,2160.0,nM,=,CHEMBL490808,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N)cc3)oc2c1,5440.0,nM,=,CHEMBL490806,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3ccc(OC)cc3o2)cc1,800.0,nM,=,CHEMBL489994,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N(C)C)c(OC)c3)cc2c1,160.0,nM,=,CHEMBL489792,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N(C)C)c(OC)c3)oc2c1,530.0,nM,=,CHEMBL521929,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL116438,active
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000.0,nM,=,CHEMBL418455,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cc1)C([3H])([3H])[3H],27.0,nM,=,CHEMBL1788111,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],58.0,nM,=,CHEMBL1788121,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(OC)cc3s2)cn1)C([3H])([3H])[3H],58.0,nM,=,CHEMBL1744459,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],19.0,nM,=,CHEMBL1744460,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2nc(-c3ccc(N(C)C)nc3)sc2c1,81.0,nM,=,CHEMBL1082545,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3cc(O)ccc3s2)cn1,74.0,nM,=,CHEMBL1082546,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CN(C)c1ncc(-c2nc3ccc(O)cc3s2)cn1,41.0,nM,=,CHEMBL1088617,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ncc(-c2nc3ccc(O)cc3s2)cn1,267.0,nM,=,CHEMBL1077196,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3ccc(C(N)=O)cc3s2)cn1,85.0,nM,=,CHEMBL1087548,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc2nc(-c3ccc(C(N)=O)nc3)sc2c1,35.0,nM,=,CHEMBL1077208,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],182.0,nM,=,CHEMBL1744461,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(OC)cc3o2)cn1)C([3H])([3H])[3H],204.0,nM,=,CHEMBL1744462,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3ccc(OC)cc3o2)cn1,185.0,nM,=,CHEMBL1082889,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],85.0,nM,=,CHEMBL1744463,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CN(C)c1ccc(-c2nc3cc(O)ccc3o2)cn1,137.0,nM,=,CHEMBL1083207,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ncc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],75.0,nM,=,CHEMBL1744464,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2cc3ccc(O)cc3o2)cn1,45.0,nM,=,CHEMBL1084943,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2cc3ccc(OC)cc3o2)cn1,66.0,nM,=,CHEMBL1084944,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2cc(-c3ccc(C(N)=O)nc3)oc2c1,60.0,nM,=,CHEMBL1084945,active
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2cc(-c3ccc(C(N)=O)cn3)oc2c1,33.0,nM,=,CHEMBL1084946,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,19.0,nM,=,CHEMBL93124,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cn1,22.0,nM,=,CHEMBL570378,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,158.0,nM,=,CHEMBL2048299,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,COc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,35.0,nM,=,CHEMBL2048300,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCCF)nc3)oc2c1,395.0,nM,=,CHEMBL2048301,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCF)nc3)sc2c1,33.0,nM,=,CHEMBL2048302,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCCF)nc3)sc2c1,66.0,nM,=,CHEMBL2048303,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,24.0,nM,=,CHEMBL579205,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)nc1F,44.0,nM,=,CHEMBL2048304,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(OC)cc3s2)c(F)n1,14.0,nM,=,CHEMBL2048305,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)c(F)n1,124.0,nM,=,CHEMBL2048306,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ncc(-c2nc3ccc(O)cc3s2)cc1F,98.0,nM,=,CHEMBL2048307,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,24.0,nM,=,CHEMBL2048308,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)c(F)n1,19.0,nM,=,CHEMBL2048309,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ncc(-c2cc3cc(O)ccc3o2)cc1F,30.0,nM,=,CHEMBL2048310,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,COc1ccc2oc(-c3ccc(C(N)=O)nc3F)cc2c1,32.0,nM,=,CHEMBL2048311,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,NC(=O)c1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,44.0,nM,=,CHEMBL2048312,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(O)ccc3o2)nc1F,35.0,nM,=,CHEMBL2048313,active
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)nc1F,32.0,nM,=,CHEMBL2048314,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,3200.0,nM,=,CHEMBL2059203,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,2100.0,nM,=,CHEMBL2059204,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,3700.0,nM,=,CHEMBL2059205,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,3400.0,nM,=,CHEMBL2059206,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,800.0,nM,=,CHEMBL2059212,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CSc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,1100.0,nM,=,CHEMBL2059218,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)cc3)c2)cc1,1600.0,nM,=,CHEMBL2059388,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(OC)c(O)c3)c2)cc1O,1600.0,nM,=,CHEMBL2059391,active
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,3300.0,nM,=,CHEMBL2059393,active
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,13000.0,nM,=,CHEMBL2063873,inactive
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,62000.0,nM,=,CHEMBL2063873,inactive
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,30000.0,nM,=,CHEMBL2063874,inactive
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,23000.0,nM,=,CHEMBL2063874,inactive
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(O)/C=C/c1ccc(O)c(O)c1,32800.0,nM,=,CHEMBL145,inactive
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,92900.0,nM,=,CHEMBL284616,inactive
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,16400.0,nM,=,CHEMBL249447,inactive
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,4700.0,nM,=,CHEMBL249448,active
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,100.0,nM,=,CHEMBL177126,active
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,2200.0,nM,=,CHEMBL2146607,active
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,300.0,nM,=,CHEMBL499997,active
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COC(=O)[C@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,3000.0,nM,=,CHEMBL2146608,active
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,Nc1c(S(=O)(=O)c2ccc(Cl)cc2)cnc2cc(-c3ccccc3)nn12,2300.0,nM,=,CHEMBL2179241,active
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,O=C(Nc1ccccc1)Nc1ccc(Cl)cc1[N+](=O)[O-],900.0,nM,=,CHEMBL2179242,active
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,O=S(=O)(Nc1ccc(N2CCCCC2)cc1)c1cc(Cl)sc1Cl,700.0,nM,=,CHEMBL2179243,active
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,Cc1nc2sc3c(c2c(=O)o1)CCCC3,1200.0,nM,=,CHEMBL1458517,active
Binding affinity to human amyloid beta plaque,IC50,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)ccc21,48.7,nM,=,CHEMBL2203390,active
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4cc[nH]c4c3)oc2n1,45.3,nM,=,CHEMBL2203389,active
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4ncsc4c3)oc2n1,35.8,nM,=,CHEMBL2203388,active
Binding affinity to human amyloid beta plaque,IC50,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)cnc21,30.2,nM,=,CHEMBL2203387,active
Binding affinity to human amyloid beta plaque,IC50,CN1CCc2cc(-c3nc4ccc(F)nc4o3)cnc21,47.0,nM,=,CHEMBL2203386,active
Binding affinity to human amyloid beta plaque,IC50,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,10.5,nM,=,CHEMBL2203385,active
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3cnc4[nH]ccc4c3)oc2n1,25.7,nM,=,CHEMBL2203384,active
Binding affinity to human amyloid beta plaque,IC50,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,8.0,nM,=,CHEMBL2203383,active
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4[nH]ccc4c3)oc2n1,13.8,nM,=,CHEMBL2203382,active
Binding affinity to human amyloid beta plaque,IC50,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cn1,41.8,nM,=,CHEMBL2203381,active
Binding affinity to human amyloid beta plaque,IC50,CNc1ccc(-c2nc3ccc(F)nc3o2)cn1,102.0,nM,=,CHEMBL2203380,active
Binding affinity to human amyloid beta plaque,IC50,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,4.0,nM,=,CHEMBL2203379,active
Binding affinity to human amyloid beta plaque,IC50,CNc1ccc(-c2nc3ccc(F)nc3o2)cc1,23.1,nM,=,CHEMBL2203378,active
Binding affinity to human amyloid beta plaque,IC50,COc1ccc(-c2nc3ccc(F)nc3o2)cc1,32.5,nM,=,CHEMBL2203288,active
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2ccc(O)c(O)c2)cc1O,1000.0,nM,=,CHEMBL2337291,active
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2ccccc2-c2ccc(O)c(O)c2)cc1O,2700.0,nM,=,CHEMBL2337290,active
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2cccc(-c3ccc(O)c(O)c3)c2)cc1O,3700.0,nM,=,CHEMBL2337293,active
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,6500.0,nM,=,CHEMBL2381403,active
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,4000.0,nM,=,CHEMBL2381384,active
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,5000.0,nM,=,CHEMBL2381385,active
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,14000.0,nM,=,CHEMBL2381402,inactive
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,21000.0,nM,=,CHEMBL2381403,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,29000.0,nM,=,CHEMBL2381402,inactive
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,1000.0,nM,=,CHEMBL2381384,active
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,29000.0,nM,=,CHEMBL2381385,inactive
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,36000.0,nM,=,CHEMBL2381386,inactive
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,36000.0,nM,=,CHEMBL2381401,inactive
Inhibition of amyloid beta fibril aggregation (unknown origin) by thioflavin T fluorescence method,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000.0,nM,=,CHEMBL247932,active
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation after 18 hrs by DELFIA,IC50,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,30000.0,nM,=,CHEMBL723,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1cccc(Oc2cnc(Nc3cccc(O)c3)nc2)c1,100000.0,nM,=,CHEMBL2386874,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,CCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]4C[C@@H]5O[C@]6(CC[C@@H](C)CO6)[C@@H](C)[C@@H]5[C@@]4(C)CC[C@@H]32)C1,100000.0,nM,=,CHEMBL2386881,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,100000.0,nM,=,CHEMBL497,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,100000.0,nM,=,CHEMBL297453,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,100000.0,nM,=,CHEMBL468154,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,NCCCS(=O)(=O)O,100000.0,nM,=,CHEMBL149082,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15110.0,nM,=,CHEMBL165,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,12350.0,nM,=,CHEMBL116438,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(NC(C)C)ccc3O)cc2)cc(OC)c1,18350.0,nM,=,CHEMBL2402063,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(NCC(C)C)ccc3O)cc2)cc(OC)c1,10320.0,nM,=,CHEMBL2402075,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CCCNc1ccc(O)c(CNc2ccc(/C=C/c3cc(OC)cc(OC)c3)cc2)c1,13070.0,nM,=,CHEMBL2402074,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,7560.0,nM,=,CHEMBL2402067,active
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccccc1CNc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,14160.0,nM,=,CHEMBL2402161,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,6510.0,nM,=,CHEMBL2402160,active
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,O=[N+]([O-])c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,7060.0,nM,=,CHEMBL2402159,active
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1cc(O)cc(/C=C/c2ccc(NCc3cccc(O)c3O)cc2)c1,7870.0,nM,=,CHEMBL2402158,active
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1cc(O)cc(/C=C/c2ccc(NCc3ccccc3O)cc2)c1,10220.0,nM,=,CHEMBL2402157,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,10660.0,nM,=,CHEMBL2402163,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,12200.0,nM,=,CHEMBL2402162,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,19700.0,nM,=,CHEMBL129795,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15900.0,nM,=,CHEMBL165,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)O)cc2)c(O)c1,18500.0,nM,=,CHEMBL2408097,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,23800.0,nM,=,CHEMBL2408096,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(Br)c(OCc3ccccc3)c(OC)c2)c(O)c1,12500.0,nM,=,CHEMBL2408095,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1,9700.0,nM,=,CHEMBL260867,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)cc2OC)c(O)c1,10200.0,nM,=,CHEMBL258752,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19100.0,nM,=,CHEMBL2408094,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,8400.0,nM,=,CHEMBL229907,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)c(O)c1,7800.0,nM,=,CHEMBL2408093,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCOc1cccc(/C=C/C(=O)c2ccc(OC)cc2O)c1,10500.0,nM,=,CHEMBL2408092,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(OCCCOc3ccccc3)c(OC)c2)c(O)c1,10900.0,nM,=,CHEMBL2408091,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1OC,5800.0,nM,=,CHEMBL2407101,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3cc([N+](=O)[O-])ccc3O)cc2)c(O)c1,13300.0,nM,=,CHEMBL2408265,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3O)cc2)c(O)c1,10100.0,nM,=,CHEMBL2408264,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3OC)cc2)c(O)c1,7300.0,nM,=,CHEMBL2408263,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccc(C)cc3C)cc2)c(O)c1,8300.0,nM,=,CHEMBL2408262,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N(C)c3ccccc3)cc2)c(O)c1,20100.0,nM,=,CHEMBL2408261,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCc3ccccc3)cc2)c(O)c1,18900.0,nM,=,CHEMBL2408106,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCCc3ccccc3)cc2)c(O)c1,19100.0,nM,=,CHEMBL2408105,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCCCCCCCCCCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,15900.0,nM,=,CHEMBL2408104,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19900.0,nM,=,CHEMBL2408103,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NC(C)C)cc2)c(O)c1,17800.0,nM,=,CHEMBL2408102,inactive
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,3200.0,nM,=,CHEMBL2408101,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCCC3)cc2)c(O)c1,5900.0,nM,=,CHEMBL2408100,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(C)CC3)cc2)c(O)c1,2200.0,nM,=,CHEMBL2408099,active
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCC3)cc2)c(O)c1,14600.0,nM,=,CHEMBL2408098,inactive
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,O=C(O)c1cccnc1,13100.0,nM,=,CHEMBL573,inactive
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,28400.0,nM,=,CHEMBL858,inactive
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(O)c1cccnc1,43700.0,nM,=,CHEMBL573,inactive
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,7700.0,nM,=,CHEMBL858,active
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,CCc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,6800.0,nM,=,CHEMBL2425961,active
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(/C=C/c1ccc2c(=O)n(CCc3ccccc3)cnc2c1)NO,5500.0,nM,=,CHEMBL2425960,active
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1c[nH]c2ccccc12,7400.0,nM,=,CHEMBL2425959,active
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,9500.0,nM,=,CHEMBL2425958,active
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1Cc1ccccc1,18100.0,nM,=,CHEMBL2425957,inactive
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1-c1ccccc1,18400.0,nM,=,CHEMBL2425955,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,20300.0,nM,=,CHEMBL116438,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,11500.0,nM,=,CHEMBL2436692,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2occc(=O)c12,12600.0,nM,=,CHEMBL2436691,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,4800.0,nM,=,CHEMBL2436690,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14100.0,nM,=,CHEMBL2436710,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2oc(-c3ccccc3)cc(=O)c12,9600.0,nM,=,CHEMBL2436704,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,6500.0,nM,=,CHEMBL2436703,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13500.0,nM,=,CHEMBL2436702,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13200.0,nM,=,CHEMBL2436701,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,17300.0,nM,=,CHEMBL2436700,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14900.0,nM,=,CHEMBL2436699,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,9800.0,nM,=,CHEMBL2436698,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14200.0,nM,=,CHEMBL2436697,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,12800.0,nM,=,CHEMBL2436696,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16400.0,nM,=,CHEMBL2436695,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13700.0,nM,=,CHEMBL2436694,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16800.0,nM,=,CHEMBL2436693,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C(=O)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O)c1ccc(-c2ccccc2)c(F)c1,6880.0,nM,=,CHEMBL3087683,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,C[C@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4430.0,nM,=,CHEMBL3087680,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,C[C@@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4770.0,nM,=,CHEMBL3087679,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,COc1ccc2c(c1)c(CC(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc3c(C)n(C(=O)c4ccc(Cl)cc4)c4ccc(OC)cc34)=CC1=O)c(C)n2C(=O)c1ccc(Cl)cc1,6110.0,nM,=,CHEMBL3087677,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3150.0,nM,=,CHEMBL3087676,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC1=C(CC(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)CC3=C(C)/C(=C\c4ccc([S+](C)[O-])cc4)c4ccc(F)cc43)=CC2=O)c2cc(F)ccc2/C1=C/c1ccc([S+](C)[O-])cc1,8180.0,nM,=,CHEMBL3087675,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830.0,nM,=,CHEMBL3087674,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by ThT-based fluorescence assay,IC50,CN(CCCCNc1c2c(nc3c(NC(=O)CNC(=O)CC[C@H](NC(=O)CNC(=O)OCc4ccccc4)C(=O)N[C@@H](Cc4ccccc4)C(=O)OCc4ccccc4)cccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2,51000.0,nM,=,CHEMBL3099500,inactive
Destabilization of preformed amyloid beta (1 to 40) (unknown origin),IC50,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,5000.0,nM,=,CHEMBL541265,active
Inhibition of amyloid beta (1 to 40) aggregation (unknown origin),IC50,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,1540.0,nM,=,CHEMBL541265,active
Inhibition of amyloid beta (unknown origin) aggregation,IC50,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200.0,nM,=,CHEMBL3235503,inactive
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccncc4)cn3c2=O)cc(OC)c1O,93.0,nM,=,CHEMBL3286981,active
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(OC)c1O,7.0,nM,=,CHEMBL3286982,active
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Cl)c1O,32.0,nM,=,CHEMBL3286983,active
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Br)c1O,18.0,nM,=,CHEMBL3286984,active
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(O)c1O,18.0,nM,=,CHEMBL3286985,active
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccncc4C)cn3c2=O)cc(OC)c1O,32.0,nM,=,CHEMBL3286987,active
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4cccc(Cl)c4)cn3c2=O)cc(OC)c1O,6.0,nM,=,CHEMBL3286988,active
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4cccc(C(F)(F)F)c4)cn3c2=O)cc(Cl)c1O,123.0,nM,=,CHEMBL3286989,active
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,550.0,nM,=,CHEMBL191083,active
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,7100.0,nM,=,CHEMBL3330739,active
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(N)=O,1500.0,nM,=,CHEMBL3330740,active
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(/C=C(\C#N)C(N)=O)s4)cc2n3C(C)(C)C)cc1,550.0,nM,=,CHEMBL3330753,active
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,Cc1ccc2oc(=O)c(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,5000.0,nM,=,CHEMBL3326707,active
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2cc(OC(F)(F)F)ccc2oc1=O,24200.0,nM,=,CHEMBL3326709,inactive
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,COc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,13400.0,nM,=,CHEMBL3327246,inactive
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,Cc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,6100.0,nM,=,CHEMBL3327247,active
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11000.0,nM,=,CHEMBL116438,inactive
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,4600.0,nM,=,CHEMBL297453,active
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2c1ccc(O)c2O,2700.0,nM,=,CHEMBL3298066,active
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6400.0,nM,=,CHEMBL151,active
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,5400.0,nM,=,CHEMBL3297746,active
Inhibition of amyloid beta1-40 (unknown origin) aggregation,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,3000.0,nM,=,CHEMBL297453,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC(=O)N6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250.0,nM,=,CHEMBL2206986,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C(=O)C(C)C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170.0,nM,=,CHEMBL2206995,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270.0,nM,=,CHEMBL2207065,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210.0,nM,=,CHEMBL2207043,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250.0,nM,=,CHEMBL2207042,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CNCCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,91.0,nM,=,CHEMBL2207069,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100.0,nM,=,CHEMBL2206994,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCOC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270.0,nM,=,CHEMBL2207044,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCN6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL2207050,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6(C)COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,400.0,nM,=,CHEMBL2206992,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CNC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100.0,nM,=,CHEMBL2206993,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,140.0,nM,=,CHEMBL3403815,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403817,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,130.0,nM,=,CHEMBL3403818,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,68.0,nM,=,CHEMBL3403819,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403820,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL3403822,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210.0,nM,=,CHEMBL3403823,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170.0,nM,=,CHEMBL3403824,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86.0,nM,=,CHEMBL3403825,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86.0,nM,=,CHEMBL3403826,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCO)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403827,active
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL3403816,active
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,IC50,O=C(Cc1ccccc1)NC(CSSCC(NC(=O)Cc1ccccc1)C(=O)O)C(=O)O,1950.0,nM,=,CHEMBL576840,active
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,IC50,CNc1ccc(C(=O)NC(CCCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,2750.0,nM,=,CHEMBL3400292,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,500.0,nM,=,CHEMBL297453,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,95900.0,nM,=,CHEMBL3582126,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCCO)c21)CCC3=O,28000.0,nM,=,CHEMBL3582127,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCO)c21)CCC3=O,34300.0,nM,=,CHEMBL3582128,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,71900.0,nM,=,CHEMBL3582129,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)[C@@H](O)C[C@@H]2O)CCC4=O,10100.0,nM,=,CHEMBL3582130,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]12CCC(=O)c3coc(c31)C(=O)C1=C2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,1200.0,nM,=,CHEMBL3582132,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12C(=O)CC[C@H]1C1=C(C[C@H]2O)[C@@]2(C)CC[C@H](O)c3coc(c32)C1=O,43500.0,nM,=,CHEMBL3582133,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)C(=O)C[C@H]2O)CCC4=O,13400.0,nM,=,CHEMBL549959,inactive
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160,active
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3110.0,nM,=,CHEMBL3087676,active
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830.0,nM,=,CHEMBL3087674,active
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccc(OCCCO[N+](=O)[O-])cc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.O=S(=O)([O-])C(F)(F)F,26000.0,nM,=,CHEMBL3593276,inactive
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccc(OCc4no[n+]([O-])c4C(N)=O)cc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21.O=S(=O)([O-])C(F)(F)F,17000.0,nM,=,CHEMBL3593277,inactive
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21.[I-],26000.0,nM,=,CHEMBL3593280,inactive
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-],3300.0,nM,=,CHEMBL81782,active
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.[I-],7700.0,nM,=,CHEMBL3593278,active
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(Oc3no[n+]([O-])c3-c3ccccc3)cc21.[I-],1600.0,nM,=,CHEMBL3593279,active
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCCOc1ccc2c(c1)N(CC)/C(=C/C=C/c1sc3ccccc3[n+]1CC)S2.[I-],800.0,nM,=,CHEMBL3593282,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)ccc1O,4300.0,nM,=,CHEMBL3594076,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1,15800.0,nM,=,CHEMBL3594077,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1O,1300.0,nM,=,CHEMBL3594078,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc(OC)c1O,2900.0,nM,=,CHEMBL3594079,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3900.0,nM,=,CHEMBL116438,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by Thioflavin-T Abeta aggregation assay,IC50,O=C(O)c1c(O)cc2c([nH]c3ccccc32)c1O,15000.0,nM,=,CHEMBL3622510,inactive
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by ThT assay,IC50,Oc1ccc(/C=C/c2ccc(O)c3ncccc23)cc1,8500.0,nM,=,CHEMBL3621634,active
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation by thioflavin-T fluorescence assay,IC50,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,3960.0,nM,=,CHEMBL3622258,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,244300.0,nM,=,CHEMBL3740785,inactive
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,269500.0,nM,=,CHEMBL3739748,inactive
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6C=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,203700.0,nM,=,CHEMBL3741300,inactive
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,186600.0,nM,=,CHEMBL3740688,inactive
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,71900.0,nM,=,CHEMBL324842,inactive
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,26000.0,nM,=,CHEMBL3741643,inactive
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,27000.0,nM,=,CHEMBL3741680,inactive
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,5600.0,nM,=,CHEMBL3741909,active
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,3400.0,nM,=,CHEMBL3741268,active
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,14500.0,nM,=,CHEMBL3742091,inactive
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,19600.0,nM,=,CHEMBL3741747,inactive
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,3500.0,nM,=,CHEMBL3741747,active
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,3900.0,nM,=,CHEMBL3742091,active
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,5100.0,nM,=,CHEMBL3741268,active
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,19500.0,nM,=,CHEMBL3741909,inactive
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,2900.0,nM,=,CHEMBL3741680,active
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,4000.0,nM,=,CHEMBL3741643,active
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccc(N3CCCC3)c2)C(=O)C1,16800.0,nM,=,CHEMBL3740581,inactive
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,4000.0,nM,=,CHEMBL3739861,active
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,30300.0,nM,=,CHEMBL28626,inactive
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,33000.0,nM,=,CHEMBL66,inactive
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,15300.0,nM,=,CHEMBL50,inactive
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,15100.0,nM,=,CHEMBL164,inactive
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100.0,nM,=,CHEMBL150,inactive
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,55400.0,nM,=,CHEMBL503168,inactive
Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T-based fluorometric assay,IC50,Cl.Cl.c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8400.0,nM,=,CHEMBL3752685,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,IC50,COc1ccc(CC(=O)Nc2nc(-c3ccccc3)cs2)cc1,10600.0,nM,=,CHEMBL3751854,inactive
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11300.0,nM,=,CHEMBL140,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,Cc1ccc(-c2cc(NCCNc3cc(-c4cccs4)[nH]n3)n[nH]2)cc1,29000.0,nM,=,CHEMBL3781419,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,CN(C)c1ccc(-c2cc(NCCNc3cc(-c4ccc(N(C)C)cc4)[nH]n3)n[nH]2)cc1,7500.0,nM,=,CHEMBL3781022,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,Fc1ccc(-c2cc(NCCNc3cc(-c4ccc(F)cc4)[nH]n3)n[nH]2)cc1,40500.0,nM,=,CHEMBL3781026,inactive
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1,71.28,nM,=,CHEMBL3797646,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,22.54,nM,=,CHEMBL3797706,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,51.81,nM,=,CHEMBL3799558,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1ccc(O)cc1)Nc1c2c(nc3ccccc13)CCCC2,45.29,nM,=,CHEMBL3798857,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,77.45,nM,=,CHEMBL3797623,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OC)cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c1,55.86,nM,=,CHEMBL3798989,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,30.74,nM,=,CHEMBL3797363,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,65.5,nM,=,CHEMBL3799703,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)ccc1O,37.36,nM,=,CHEMBL3797381,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)c1ccc(O)c(O)c1)Nc1c2c(nc3ccccc13)CCCC2,17.36,nM,=,CHEMBL3800453,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,49.14,nM,=,CHEMBL3800317,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,45.88,nM,=,CHEMBL3799950,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1O,46.12,nM,=,CHEMBL3798813,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)/C=C/c1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,51.77,nM,=,CHEMBL3799175,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1c[nH]c2ccccc12)Nc1c2c(nc3ccccc13)CCCC2,38.96,nM,=,CHEMBL3799641,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,Nc1c2c(nc3ccccc13)CCCC2,12.21,nM,=,CHEMBL95,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,4100.0,nM,=,CHEMBL165,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3100.0,nM,=,CHEMBL140,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,14700.0,nM,=,CHEMBL3813837,inactive
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700.0,nM,=,CHEMBL3814001,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,2700.0,nM,=,CHEMBL3814125,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,8100.0,nM,=,CHEMBL3815148,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,13400.0,nM,=,CHEMBL3814191,inactive
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,5300.0,nM,=,CHEMBL3814611,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,13800.0,nM,=,CHEMBL3815150,inactive
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,22500.0,nM,=,CHEMBL3813859,inactive
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,8400.0,nM,=,CHEMBL3814134,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],8700.0,nM,=,CHEMBL410263,active
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,14800.0,nM,=,CHEMBL3814631,inactive
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,22300.0,nM,=,CHEMBL3814270,inactive
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,21000.0,nM,=,CHEMBL3814349,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,2600.0,nM,=,CHEMBL165,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1500.0,nM,=,CHEMBL140,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900.0,nM,=,CHEMBL3814610,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,11300.0,nM,=,CHEMBL3813837,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700.0,nM,=,CHEMBL3814001,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,1500.0,nM,=,CHEMBL3814125,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,930.0,nM,=,CHEMBL3815148,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,5900.0,nM,=,CHEMBL3814191,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,2300.0,nM,=,CHEMBL3814611,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,12500.0,nM,=,CHEMBL3815150,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)c3ccccc3n2)cc1,6800.0,nM,=,CHEMBL3814909,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,13100.0,nM,=,CHEMBL3813859,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,2200.0,nM,=,CHEMBL3814134,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],3000.0,nM,=,CHEMBL410263,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCC2CCCCC2)c2ccccc2n1,13600.0,nM,=,CHEMBL3815002,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CC(C)Nc1nc(N)nc2ccccc12,10200.0,nM,=,CHEMBL3814965,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CCCNc1nc(N)nc2ccccc12,14900.0,nM,=,CHEMBL3814813,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800.0,nM,=,CHEMBL3814123,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(F)cc2)c2ccccc2n1,3100.0,nM,=,CHEMBL3357256,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)c2ccccc2n1,2800.0,nM,=,CHEMBL3814748,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,80.0,nM,=,CHEMBL3814631,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,580.0,nM,=,CHEMBL3814270,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,620.0,nM,=,CHEMBL3813811,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)c2ccccc2n1,1900.0,nM,=,CHEMBL3814383,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)c2ccccc2n1,1900.0,nM,=,CHEMBL3814660,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,3500.0,nM,=,CHEMBL3814349,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)nc3ccccc23)cc1,1100.0,nM,=,CHEMBL3813788,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cccc(CNc2nc(N)nc3ccccc23)c1,20600.0,nM,=,CHEMBL3814429,inactive
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)nc3ccccc23)cc1,3900.0,nM,=,CHEMBL3813971,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1cccc(CNc2nc(N)nc3ccccc23)c1,3600.0,nM,=,CHEMBL3814363,active
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800.0,nM,=,CHEMBL3815078,active
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000.0,nM,=,CHEMBL140,active
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1300.0,nM,=,CHEMBL429694,active
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(NCCc3ccccn3)n2)n1,35000.0,nM,=,CHEMBL3815004,inactive
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCCc2cccc(NCCCc3ccccn3)n2)n1,17000.0,nM,=,CHEMBL3814529,inactive
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCc2cccc(NCCc3ccccn3)n2)n1,25000.0,nM,=,CHEMBL3814719,inactive
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCc2cccc(NCc3ccccn3)n2)n1,13000.0,nM,=,CHEMBL3814159,inactive
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(CCN(c3ccccn3)c3ccccn3)n2)n1,240000.0,nM,=,CHEMBL3813916,inactive
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(CCNc3ccccn3)n2)n1,280000.0,nM,=,CHEMBL3814563,inactive
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,9200.0,nM,=,CHEMBL3818600,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,11750.0,nM,=,CHEMBL3819454,inactive
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,10110.0,nM,=,CHEMBL3818053,inactive
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810.0,nM,=,CHEMBL140,inactive
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc(O)cc1OC,4600.0,nM,=,CHEMBL3942680,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.[Cl-],500.0,nM,=,CHEMBL405110,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccn2)ccc1/C=C/c1cc(/C=C/c2ccc3cc[nH]c3c2)[nH]n1,1200.0,nM,=,CHEMBL3953399,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccn2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,470.0,nM,=,CHEMBL3948937,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccc2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,5400.0,nM,=,CHEMBL3901022,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCC2CCCO2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,2500.0,nM,=,CHEMBL3938007,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)c(OC)c1,610.0,nM,=,CHEMBL3965306,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,520.0,nM,=,CHEMBL3911126,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccco2)ccc1O,760.0,nM,=,CHEMBL3981143,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccccc2)ccc1O,2200.0,nM,=,CHEMBL3892054,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)ccc1O,420.0,nM,=,CHEMBL3950384,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3ccccc3c2)ccc1O,590.0,nM,=,CHEMBL3922663,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3c(c2)OCO3)ccc1O,3700.0,nM,=,CHEMBL3978488,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c(O)c1,930.0,nM,=,CHEMBL3672436,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1100.0,nM,=,CHEMBL3970179,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(O)c(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1800.0,nM,=,CHEMBL3940632,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)cc2OC)ccc1O,920.0,nM,=,CHEMBL3672401,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cc(O)ccc2OC)ccc1O,1300.0,nM,=,CHEMBL3969106,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2c(O)cccc2OC)ccc1O,1600.0,nM,=,CHEMBL3672439,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1O,2100.0,nM,=,CHEMBL3958051,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(O)c2OC)ccc1O,1900.0,nM,=,CHEMBL3911667,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(OC)c2O)ccc1O,5400.0,nM,=,CHEMBL3986412,active
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,5400.0,nM,=,CHEMBL140,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,9470.0,nM,=,CHEMBL3922564,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18250.0,nM,=,CHEMBL140,inactive
Inhibition of human amyloid beta (1 to 42) aggregation incubated for 48 hrs under dark condition by ThT fluorescence assay,IC50,OC[C@@H]1Cc2c([nH]c3ccccc23)CN1Cc1cn(C[C@@H]2Cc3c([nH]c4ccccc34)CN2)nn1,66360.0,nM,=,CHEMBL3883958,inactive
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,630.0,nM,=,CHEMBL140,active
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin),IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,7940.0,nM,=,CHEMBL50,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc1)C2,12200.0,nM,=,CHEMBL3944195,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,7400.0,nM,=,CHEMBL3925265,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccoc4)CC3)cc1)C2,10900.0,nM,=,CHEMBL3913721,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2,9900.0,nM,=,CHEMBL3951861,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810.0,nM,=,CHEMBL140,inactive
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CCS(=O)(=O)NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,1.0,nM,=,CHEMBL1086286,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,14.0,nM,=,CHEMBL1086287,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CC(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,7.0,nM,=,CHEMBL3659993,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCO[C@@H](CCC(O)CO)[C@@H]1COc1c(F)ccc(F)c12,15.0,nM,=,CHEMBL3659994,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C1CC1,8.0,nM,=,CHEMBL1090210,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=C(C[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)NCC(F)(F)F,25.0,nM,=,CHEMBL3659995,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CCS(=O)(=O)CC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,10.0,nM,=,CHEMBL3659992,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C(F)(F)F,27.0,nM,=,CHEMBL1090209,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@]2(O)C1)C1CC1,29.0,nM,=,CHEMBL1778349,active
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,54.0,nM,=,CHEMBL1085076,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)CC(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,210.0,nM,=,CHEMBL3667019,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,440.0,nM,=,CHEMBL3667020,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,520.0,nM,=,CHEMBL3667022,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,310.0,nM,=,CHEMBL3667023,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CCOC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,380.0,nM,=,CHEMBL3667024,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CC(C)(C)OC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,650.0,nM,=,CHEMBL3667025,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,1300.0,nM,=,CHEMBL3667026,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CCOC(=O)C(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,140.0,nM,=,CHEMBL3667027,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc([O-])c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc([O-])c(OC(F)(F)F)c1.[Na+].[Na+],560.0,nM,=,CHEMBL3667028,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COCOCCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500.0,nM,=,CHEMBL3667029,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CN(C)C(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500.0,nM,=,CHEMBL3667030,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(CCOCCO)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,700.0,nM,=,CHEMBL3667031,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1OC,140.0,nM,=,CHEMBL3667032,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OCC(=O)O)c(OC)c2)ccc1O,310.0,nM,=,CHEMBL3667033,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(C(F)(F)F)c2)ccc1O,130.0,nM,=,CHEMBL3639383,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CNc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(NC)c(C(F)(F)F)c2)cc1C(F)(F)F,5800.0,nM,=,CHEMBL3667034,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cncc(C(F)(F)F)c2)ccc1O,100.0,nM,=,CHEMBL3667035,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1,360.0,nM,=,CHEMBL3667036,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,N#CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,300.0,nM,=,CHEMBL3667037,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,320.0,nM,=,CHEMBL3667038,active
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccco1,650.0,nM,=,CHEMBL3667039,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@]21N=C(C)C(N)=N1,2.0,nM,=,CHEMBL4112651,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@@]21N=C(C)C(N)=N1,1.6,nM,=,CHEMBL3893021,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,56.0,nM,=,CHEMBL3959097,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1[C@@]21N=C(C)C(N)=N1,0.7,nM,=,CHEMBL3898248,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,1.6,nM,=,CHEMBL3672698,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC[C@@H](C)Oc1ccc2c(c1)C1(N=C(C)C(N)=N1)[C@]1(CC[C@H](OC)CC1)C2,16.0,nM,=,CHEMBL3672702,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,2.4,nM,=,CHEMBL3672687,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@@]2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,96.0,nM,=,CHEMBL3672688,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,2.1,nM,=,CHEMBL3891777,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1C21N=C(C)C(N)=N1,678.0,nM,=,CHEMBL3945110,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@]21N=C(C)C(N)=N1,0.7,nM,=,CHEMBL4110988,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,0.6,nM,=,CHEMBL3959097,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@]2(N=C1N)c1cc(OCCCF)ccc1C[C@]21CC[C@@H](OC(F)F)CC1,1.6,nM,=,CHEMBL3672695,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC(C)F)cc1C21N=C(C)C(N)=N1,2.5,nM,=,CHEMBL3899321,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,216.0,nM,=,CHEMBL3672699,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](O)CC2)C3)c1,1.0,nM,=,CHEMBL3653726,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,[C-]#[N+]c1cc(Cl)cc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,12.0,nM,=,CHEMBL3937729,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,1.7,nM,=,CHEMBL3947671,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@]21N=C(C)C(N)=N1,986.0,nM,=,CHEMBL4113193,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,4.8,nM,=,CHEMBL3943188,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,17.0,nM,=,CHEMBL3913223,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COC1CCC2(CC1)Cc1cc(F)c(Br)cc1C21N=C(C)C(N)=N1,176.0,nM,=,CHEMBL3672708,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,0.8,nM,=,CHEMBL3902640,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cncc(Cl)c3)cc1C21N=C(C)C(N)=N1,3.0,nM,=,CHEMBL3969309,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,7.4,nM,=,CHEMBL3916194,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(C#N)c3)ccc1CCC21CC1,23.0,nM,=,CHEMBL3672718,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(F)c3)ccc1CCC21CC1,118.0,nM,=,CHEMBL3672719,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cncc(Cl)c3)ccc1CCC21CC1,11.0,nM,=,CHEMBL3672720,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(Br)cc3C23N=C(C)C(N)=N3)CC1,78.0,nM,=,CHEMBL3672721,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,1.0,nM,=,CHEMBL3672723,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,80.0,nM,=,CHEMBL3672724,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,2.5,nM,=,CHEMBL3672725,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,19.0,nM,=,CHEMBL3672726,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,81.0,nM,=,CHEMBL3672727,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,2.4,nM,=,CHEMBL3672728,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1CCC21CC1,16.0,nM,=,CHEMBL3672729,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COC1CCC2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,3.1,nM,=,CHEMBL3672730,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,92.0,nM,=,CHEMBL3672731,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,4.5,nM,=,CHEMBL3672732,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3(C)CC3)cc1C21N=C(C)C(N)=N1,2.8,nM,=,CHEMBL3915935,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC(F)(F)C3)cc1C21N=C(C)C(N)=N1,8.4,nM,=,CHEMBL3891403,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1C21N=C(C)C(N)=N1,1.6,nM,=,CHEMBL3923244,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1[C@@]21N=C(C)C(N)=N1,0.9,nM,=,CHEMBL3937398,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3(F)F)cc1C21N=C(C)C(N)=N1,2.3,nM,=,CHEMBL3905816,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1C21N=C(C)C(N)=N1,1.5,nM,=,CHEMBL3961886,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,1.3,nM,=,CHEMBL3927449,active
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC3CC3)cc1C21N=C(C)C(N)=N1,0.8,nM,=,CHEMBL3939963,active
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with -secretase (40 g/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 g/l BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37 C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1)c1ccc(C(F)(F)F)cc1,1000.0,nM,=,CHEMBL3692695,active
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with -secretase (40 g/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 g/l BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37 C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(Cc1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,800.0,nM,=,CHEMBL3692696,active
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with -secretase (40 g/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 g/l BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37 C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(CCc1cc(C(F)(F)F)ccc1C(F)(F)F)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,630000.0,nM,=,CHEMBL3692697,inactive
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with -secretase (40 g/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 g/l BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37 C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(CCOc1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,20000.0,nM,=,CHEMBL3692698,inactive
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with -secretase (40 g/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 g/l BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37 C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(/C=C/c1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,84000.0,nM,=,CHEMBL3692699,inactive
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with -secretase (40 g/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 g/l BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37 C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,200000.0,nM,=,CHEMBL3692700,inactive
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with -secretase (40 g/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 g/l BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37 C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,CN1C(=O)[C@@H](NCC(=O)Nc2ccc3c(c2)C[C@H]2CC[C@@H](C3)[C@H]2NS(=O)(=O)c2ccc(Cl)s2)N=C(c2ccccc2)c2ccccc21,800000.0,nM,=,CHEMBL3692701,inactive
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,840.0,nM,=,CHEMBL4111029,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C)N=C(N)OCC2(F)F)n1,7.0,nM,=,CHEMBL4114267,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)N=C(N)OCC1(F)F,8.0,nM,=,CHEMBL2386720,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC1(C)OC(N)=N[C@](C)(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)C1(F)F,7.0,nM,=,CHEMBL2386721,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3C)ccc2F)N=C(N)OCC1(F)F,49.0,nM,=,CHEMBL2386722,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,380.0,nM,=,CHEMBL4108431,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,27.0,nM,=,CHEMBL2386723,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,140.0,nM,=,CHEMBL4110279,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)N=C(N)OCC1(F)F,12.0,nM,=,CHEMBL2386724,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,600.0,nM,=,CHEMBL4108635,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,440.0,nM,=,CHEMBL2386725,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,310.0,nM,=,CHEMBL4114995,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(C)c1,82.0,nM,=,CHEMBL4111654,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)c1,540.0,nM,=,CHEMBL4110143,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCF)nc3N)ccc2F)N=C(N)OCC1(F)F,30.0,nM,=,CHEMBL4110172,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3N)ccc2F)N=C(N)OCC1(F)F,62.0,nM,=,CHEMBL4107314,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(F)cc3N)ccc2F)N=C(N)OCC1(F)F,88.0,nM,=,CHEMBL4109969,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3N)ccc2F)N=C(N)OCC1(F)F,45.0,nM,=,CHEMBL4115329,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncccc3Cl)ccc2F)N=C(N)OCC1(F)F,88.0,nM,=,CHEMBL4106556,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,81.0,nM,=,CHEMBL4107875,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,60.0,nM,=,CHEMBL4112705,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCCl)nc3N)ccc2F)N=C(N)OCC1(F)F,2900.0,nM,=,CHEMBL4114553,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,250.0,nM,=,CHEMBL4115141,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,480.0,nM,=,CHEMBL4108335,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCF)cc3Cl)ccc2F)N=C(N)OCC1(F)F,57.0,nM,=,CHEMBL4111699,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,450.0,nM,=,CHEMBL4109860,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCCc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,70.0,nM,=,CHEMBL4110497,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,13.0,nM,=,CHEMBL2386726,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3nccnc3N)ccc2F)N=C(N)OCC1(F)F,180.0,nM,=,CHEMBL4110655,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3Cl)ccc2F)N=C(N)OCC1(F)F,19.0,nM,=,CHEMBL4113786,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)cc3N)ccc2F)N=C(N)OCC1(F)F,66.0,nM,=,CHEMBL4112589,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1nc(N)c(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)nc1Cl,6500.0,nM,=,CHEMBL4108644,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)OCC1(F)F,14.0,nM,=,CHEMBL2386719,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,58.0,nM,=,CHEMBL4111183,active
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,310.0,nM,=,CHEMBL4111103,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)CCn1cccn1,1.4,nM,=,CHEMBL3943313,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ccccn1,1.9,nM,=,CHEMBL3934479,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1cccnc1,6.6,nM,=,CHEMBL3961972,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ncon1,1.7,nM,=,CHEMBL3956918,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,Cc1nc(CS(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)no1,5.8,nM,=,CHEMBL3957316,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=c1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)c[nH]1,18.7,nM,=,CHEMBL3971184,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cccnn1,4.5,nM,=,CHEMBL3948649,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cnccn1,5.5,nM,=,CHEMBL3904071,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccnnc1,10.2,nM,=,CHEMBL3935559,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ncccn1,6.4,nM,=,CHEMBL3928118,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccncn1,2.9,nM,=,CHEMBL3900140,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cncnc1,12.9,nM,=,CHEMBL3909054,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,COc1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)cn1,16.5,nM,=,CHEMBL3905561,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=c1[nH]cccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,2.8,nM,=,CHEMBL3941787,active
"Electrochemiluminescence (ECL)-based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,Nc1ncccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,18.0,nM,=,CHEMBL3984227,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,CC1(C)OCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,66.6,nM,=,CHEMBL3629737,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(COC3)[C@@H]1COc1c(F)ccc(F)c12,10.1,nM,=,CHEMBL3629739,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCC[C@]3(CCOC3)[C@@H]1COc1c(F)ccc(F)c12,13.9,nM,=,CHEMBL3629738,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=C1OCC[C@]12CCC[C@@]1(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]21,228.0,nM,=,CHEMBL3629740,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(CCSCC3)[C@@H]1COc1c(F)ccc(F)c12,26.4,nM,=,CHEMBL3629742,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S1(=O)CCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CC1,57.7,nM,=,CHEMBL3629741,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(N1CC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)C1)C(F)(F)F,23.3,nM,=,CHEMBL3629743,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,9.5,nM,=,CHEMBL3899794,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,421.0,nM,=,CHEMBL3936795,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,397.0,nM,=,CHEMBL3905228,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,79.0,nM,=,CHEMBL3942223,active
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure -secretase activity, membranes were incubated at 37 C. for 1 h in 50 L of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, A 40 and A 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. A 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while A 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,CP1(=O)OCC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,5.4,nM,=,CHEMBL3629745,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2cccc(F)c2)[nH]cc1O,18970.0,nM,=,CHEMBL4059796,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1cccc(F)c1,19440.0,nM,=,CHEMBL4077009,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CN(C)c1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,29220.0,nM,=,CHEMBL4092433,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CCOc1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,23390.0,nM,=,CHEMBL4074429,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,8940.0,nM,=,CHEMBL4097746,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)c[nH]1,16500.0,nM,=,CHEMBL4070599,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)cn1C,12480.0,nM,=,CHEMBL4086825,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)[nH]cc1O,10720.0,nM,=,CHEMBL4074006,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(O)cc1,15380.0,nM,=,CHEMBL4068105,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccccc2O)[nH]cc1O,21760.0,nM,=,CHEMBL4095488,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890.0,nM,=,CHEMBL165,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730.0,nM,=,CHEMBL140,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2ncc(Nc3ccc4cc[nH]c4n3)cc2[nH]1,23800.0,nM,=,CHEMBL4069995,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,N#Cc1c[nH]c2nc(Nc3ccc4c(C5CCNCC5)c[nH]c4c3)ccc12,17800.0,nM,=,CHEMBL4072261,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2[nH]cc(C3CCNCC3)c2c1,26600.0,nM,=,CHEMBL4066527,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2c(C3CCNCC3)c[nH]c2n1,25600.0,nM,=,CHEMBL4104210,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,CN1CCC(c2c[nH]c3cc(Nc4ccc5[nH]cc(C6CCN(C)CC6)c5c4)ccc23)CC1,15300.0,nM,=,CHEMBL4096474,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cc1F,24000.0,nM,=,CHEMBL4088780,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3n2)cc1F,30000.0,nM,=,CHEMBL4098927,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,FC(F)(F)c1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cn1,24000.0,nM,=,CHEMBL4104620,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,CN1CCC(c2c[nH]c3cc(Nc4ccc(F)c(F)c4)ccc23)CC1,48000.0,nM,=,CHEMBL4063009,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(Nc2ccc3c(C4CCN(C)CC4)c[nH]c3c2)cc1OC,25000.0,nM,=,CHEMBL4084675,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Cn1cc(C2CCNCC2)c2ccc(Nc3ccc(F)c(F)c3)cc21,42000.0,nM,=,CHEMBL4101130,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1300.0,nM,=,CHEMBL429694,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000.0,nM,=,CHEMBL140,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Clc1nc(NCc2ccccc2)c2ccccc2n1,16700.0,nM,=,CHEMBL118193,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,8200.0,nM,=,CHEMBL4087140,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Clc1nc(NCCc2ccccc2)c2ccccc2n1,5000.0,nM,=,CHEMBL4065718,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,2300.0,nM,=,CHEMBL4070983,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2ncnc3ccccc23)cc1OC,12000.0,nM,=,CHEMBL4092601,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CCNc2ncnc3ccccc23)cc1,11900.0,nM,=,CHEMBL117804,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(N=[N+]=[N-])nc3ccccc23)cc1OC,7200.0,nM,=,CHEMBL4089722,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,[N-]=[N+]=Nc1nc(NCc2ccccc2)c2ccccc2n1,2600.0,nM,=,CHEMBL4079415,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(N)nc3ccccc23)cc1OC,8400.0,nM,=,CHEMBL4097449,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800.0,nM,=,CHEMBL3815078,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(N)nc3ccccc23)cc1OC,2700.0,nM,=,CHEMBL4071318,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800.0,nM,=,CHEMBL3814123,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(O)nc3ccccc23)cc1OC,7800.0,nM,=,CHEMBL4081859,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1nc(NCc2ccccc2)c2ccccc2n1,270.0,nM,=,CHEMBL4082825,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(O)nc3ccccc23)cc1OC,10400.0,nM,=,CHEMBL4100806,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1nc(NCCc2ccccc2)c2ccccc2n1,11200.0,nM,=,CHEMBL4096595,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,2200.0,nM,=,CHEMBL3814134,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900.0,nM,=,CHEMBL3814610,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,8300.0,nM,=,CHEMBL4060687,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,13300.0,nM,=,CHEMBL4081013,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,14400.0,nM,=,CHEMBL4099046,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,1000.0,nM,=,CHEMBL4070380,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,3100.0,nM,=,CHEMBL4091317,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,1900.0,nM,=,CHEMBL4061746,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,1700.0,nM,=,CHEMBL4083524,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,8300.0,nM,=,CHEMBL4097374,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCc2ccccc2)c2ccccc2n1,7000.0,nM,=,CHEMBL4079345,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,5000.0,nM,=,CHEMBL4105088,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,4400.0,nM,=,CHEMBL3262251,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,5700.0,nM,=,CHEMBL4067481,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,6600.0,nM,=,CHEMBL4094911,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,2900.0,nM,=,CHEMBL4078382,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,4300.0,nM,=,CHEMBL4102655,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,4900.0,nM,=,CHEMBL4086248,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CNc1nc(NCCc2ccccc2)c2ccccc2n1,2000.0,nM,=,CHEMBL4064773,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,1400.0,nM,=,CHEMBL4061837,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,4400.0,nM,=,CHEMBL4083601,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,3800.0,nM,=,CHEMBL4070462,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,790.0,nM,=,CHEMBL4091385,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3300.0,nM,=,CHEMBL140,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,1100.0,nM,=,CHEMBL165,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,13000.0,nM,=,CHEMBL4087140,inactive
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,8400.0,nM,=,CHEMBL3814134,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9900.0,nM,=,CHEMBL140,active
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15300.0,nM,=,CHEMBL165,inactive
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) fibril formation by thioflavin-T fluorescence based assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1000.0,nM,=,CHEMBL140,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,124600.0,nM,=,CHEMBL50,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,14800.0,nM,=,CHEMBL164,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O,12800.0,nM,=,CHEMBL3348861,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100.0,nM,=,CHEMBL150,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,176200.0,nM,=,CHEMBL28,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 1 hr by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL140,active
Inhibition of human amyloid beta (1 to 42) aggregation after 46 to 48 hrs by Thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,10000.0,nM,=,CHEMBL140,active
Inhibition of recombinant amyloid beta (1 to 42) fibrils (unknown origin) by thioflavin-T fluorescence assay,IC50,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,23000.0,nM,=,CHEMBL28,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,5700.0,nM,=,CHEMBL241190,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,22700.0,nM,=,CHEMBL4126558,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,87800.0,nM,=,CHEMBL4126715,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccccc1)C(=O)O,72900.0,nM,=,CHEMBL2392127,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1,4900.0,nM,=,CHEMBL2296789,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@H](Cc1ccc(O)c(O)c1)C(=O)O,1600.0,nM,=,CHEMBL115421,active
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(CCc1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,8700.0,nM,=,CHEMBL4127090,active
Displacement of [125I]IMPY from fibrillar amyloid beta 42 (unknown origin) after 3 hrs,IC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,138.0,nM,=,CHEMBL181529,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1,9000.0,nM,=,CHEMBL4166095,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8400.0,nM,=,CHEMBL32823,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,C=CCOC(=S)/C=C/c1ccc(O)c(O)c1,12500.0,nM,=,CHEMBL4175715,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,10430.0,nM,=,CHEMBL4176742,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,11550.0,nM,=,CHEMBL4172159,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccc(F)cc4)n3)CC2)n2ncnc2n1,15890.0,nM,=,CHEMBL4161552,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccccc4F)n3)CC2)n2ncnc2n1,13400.0,nM,=,CHEMBL4168812,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(Nc4ccc(F)c(Cl)c4)n3)CC2)n2ncnc2n1,16290.0,nM,=,CHEMBL4173299,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Nc4ccc(F)cc4)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,18310.0,nM,=,CHEMBL4161947,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Nc3ccc(F)c(Cl)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,25000.0,nM,=,CHEMBL4169871,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,FC(F)(F)c1cccc(Nc2nc(NC3CC3)nc(N3CCNCC3)n2)c1,23540.0,nM,=,CHEMBL4167322,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)c(F)c1,17850.0,nM,=,CHEMBL4175196,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,18550.0,nM,=,CHEMBL4170265,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,20720.0,nM,=,CHEMBL4162346,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,17600.0,nM,=,CHEMBL4166865,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,18050.0,nM,=,CHEMBL4163412,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,23800.0,nM,=,CHEMBL4174114,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,22510.0,nM,=,CHEMBL140,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,5840.0,nM,=,CHEMBL4176559,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2cscn2)nn1,8280.0,nM,=,CHEMBL4161849,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,14990.0,nM,=,CHEMBL140,inactive
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,IC50,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@@H](c2ccc(O)c(OC)c2)[C@H](CO)O4)[C@@H](O)C3=O)ccc1O,43600.0,nM,=,CHEMBL4217978,inactive
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,IC50,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@H](c2ccc(O)c(OC)c2)[C@@H](CO)O4)[C@@H](O)C3=O)ccc1O,85500.0,nM,=,CHEMBL4207221,inactive
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,7000.0,nM,=,CHEMBL76,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,4000.0,nM,=,CHEMBL682,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,4500.0,nM,=,CHEMBL138623,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1500.0,nM,=,CHEMBL317760,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,10000.0,nM,=,CHEMBL451753,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,3100.0,nM,=,CHEMBL94521,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,2500.0,nM,=,CHEMBL4227472,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1700.0,nM,=,CHEMBL97247,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2000.0,nM,=,CHEMBL319756,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,5100.0,nM,=,CHEMBL167970,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,2300.0,nM,=,CHEMBL4226945,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4100.0,nM,=,CHEMBL4226951,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,8200.0,nM,=,CHEMBL4225842,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,4600.0,nM,=,CHEMBL4226025,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,6600.0,nM,=,CHEMBL4225563,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,6200.0,nM,=,CHEMBL4228998,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,12800.0,nM,=,CHEMBL76,inactive
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,5400.0,nM,=,CHEMBL682,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,10400.0,nM,=,CHEMBL138623,inactive
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2800.0,nM,=,CHEMBL317760,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,13800.0,nM,=,CHEMBL451753,inactive
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,7100.0,nM,=,CHEMBL94521,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,4900.0,nM,=,CHEMBL4227472,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2900.0,nM,=,CHEMBL97247,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2100.0,nM,=,CHEMBL319756,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,11200.0,nM,=,CHEMBL167970,inactive
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,1900.0,nM,=,CHEMBL4226945,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4700.0,nM,=,CHEMBL4226951,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,6000.0,nM,=,CHEMBL4226025,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,7900.0,nM,=,CHEMBL4225563,active
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,9400.0,nM,=,CHEMBL4228998,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,12430.0,nM,=,CHEMBL165,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,8860.0,nM,=,CHEMBL4228823,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,18940.0,nM,=,CHEMBL4226059,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,11440.0,nM,=,CHEMBL4227890,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(F)cc1F)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5050.0,nM,=,CHEMBL4227615,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,N#Cc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,16810.0,nM,=,CHEMBL4226505,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,7350.0,nM,=,CHEMBL4227357,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Cc1ccccc1/C=C/C(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,17330.0,nM,=,CHEMBL4228027,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,22550.0,nM,=,CHEMBL4225226,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,19740.0,nM,=,CHEMBL4225986,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5640.0,nM,=,CHEMBL4226827,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,18280.0,nM,=,CHEMBL4226831,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,20610.0,nM,=,CHEMBL4225989,inactive
Inhibition of beta amyloid (unknown origin) deposition,IC50,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,45000.0,nM,=,CHEMBL194823,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2cccc(F)c2)occ1O,17680.0,nM,=,CHEMBL4282190,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,CN(C)c1ccc(/C=C/c2cc(=O)c(O)co2)cc1,5920.0,nM,=,CHEMBL4294375,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)co1,7930.0,nM,=,CHEMBL4286002,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7200.0,nM,=,CHEMBL4287929,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccccc2O)occ1O,8290.0,nM,=,CHEMBL4284208,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2cc(O)cc(O)c2)occ1O,17950.0,nM,=,CHEMBL4294830,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890.0,nM,=,CHEMBL165,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730.0,nM,=,CHEMBL140,inactive
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4200.0,nM,=,CHEMBL197478,active
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(O)/C=C/c1ccc(O)c(O)c1,15600.0,nM,=,CHEMBL145,inactive
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3400.0,nM,=,CHEMBL140,active
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4900.0,nM,=,CHEMBL197478,active
Inhibition of APP (unknown origin),IC50,O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1,199.53,nM,=,CHEMBL289556,active
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) incubated for 24 hrs by TEM analysis,IC50,CCN(CC)CCCOc1ccc(-n2ccc(=O)c(O)c2C)cc1,17230.0,nM,=,CHEMBL4462662,inactive
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation,IC50,CCN(CC)CCCCC(C)Nc1c2ccccc2nc2c(C(=O)NCCCO/N=C/C(=O)NCCCC[C@@H]3NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C3=O)cccc12,2000.0,nM,=,CHEMBL4465480,active
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation by thioflavin T based fluorescence assay,IC50,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200.0,nM,=,CHEMBL3235503,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation,IC50,Cl.O=c1c2c(F)cccc2[se]n1-c1cc(Cl)c(O)c2ncccc12,9600.0,nM,=,CHEMBL4438040,active
Inhibition of amyloid beta 1 to 42 aggregation in human SH-SY5Y cells incubated for 48 hrs by fluorescence microscopy,IC50,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,60.0,nM,=,CHEMBL4475538,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,IC50,CCOC(=O)C(Cc1cn(-c2ccccc2C(F)(F)F)nn1)(Cc1cn(-c2ccccc2C(F)(F)F)nn1)NC(C)=O,8065.0,nM,=,CHEMBL4522050,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,6385.0,nM,=,CHEMBL140,active
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,46420.0,nM,=,CHEMBL4568384,inactive
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,44520.0,nM,=,CHEMBL4439214,inactive
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccccc3c2C=C1c1cc(O)cc(O)c1,12600.0,nM,=,CHEMBL4588767,inactive
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3cc(O)ccc3c2C=C1c1cc(O)cc(O)c1,8900.0,nM,=,CHEMBL4552863,active
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccc(O)cc3c2C=C1c1cc(O)cc(O)c1,4900.0,nM,=,CHEMBL4455417,active
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3cc(O)ccc3c2C=C1c1ccc(O)c(O)c1,4600.0,nM,=,CHEMBL4476718,active
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccc(O)cc3c2C=C1c1ccc(O)c(O)c1,3400.0,nM,=,CHEMBL4444573,active
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2cc(O)ccc2C=C1c1cc(O)cc(O)c1,21700.0,nM,=,CHEMBL4466197,inactive
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc(O)cc2C=C1c1ccc(O)c(O)c1,17500.0,nM,=,CHEMBL4468824,inactive
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,16800.0,nM,=,CHEMBL165,inactive
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,13700.0,nM,=,CHEMBL140,inactive
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3980.0,nM,=,CHEMBL4524631,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,4200.0,nM,=,CHEMBL4516540,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2OC)cc1O,3630.0,nM,=,CHEMBL4439936,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,2410.0,nM,=,CHEMBL4562198,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3550.0,nM,=,CHEMBL4440350,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,3860.0,nM,=,CHEMBL4527242,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2OC)cc1O,3450.0,nM,=,CHEMBL4474151,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3050.0,nM,=,CHEMBL4553651,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2N(C)C)cc1O)Cc1ccccc1N(C)C,3710.0,nM,=,CHEMBL4554367,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccc(N(C)C)cc2)cc1O)Cc1ccc(N(C)C)cc1,3160.0,nM,=,CHEMBL4463164,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,O=C(NCCCCN1CCOc2ccccc2C1)c1cc(O)c(C(=O)NCCCCN2CCOc3ccccc3C2)cc1O,5470.0,nM,=,CHEMBL4467746,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,2370.0,nM,=,CHEMBL4552250,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,2800.0,nM,=,CHEMBL4520323,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2OC)cc1O,2310.0,nM,=,CHEMBL4475678,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3310.0,nM,=,CHEMBL4451935,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160,active
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1cc(-c2ccc(Oc3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)cc2)oc2cc(O)cc(O)c12,9500.0,nM,=,CHEMBL291426,active
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3o2)cc1,45600.0,nM,=,CHEMBL4513568,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,17300.0,nM,=,CHEMBL4463033,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4c(OC)cc5oc(-c6ccc(O)cc6)cc(=O)c5c4O)c3o2)cc1,15900.0,nM,=,CHEMBL4554693,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,32800.0,nM,=,CHEMBL4545404,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,13000.0,nM,=,CHEMBL4449738,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,21300.0,nM,=,CHEMBL3589107,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,20100.0,nM,=,CHEMBL374055,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,10100.0,nM,=,CHEMBL1208903,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,13200.0,nM,=,CHEMBL377324,inactive
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,4900.0,nM,=,CHEMBL220745,active
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,4700.0,nM,=,CHEMBL378188,active
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(O)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,4900.0,nM,=,CHEMBL255493,active
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,4800.0,nM,=,CHEMBL63354,active
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,4100.0,nM,=,CHEMBL164,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,IC50,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,17440.0,nM,=,CHEMBL4436866,inactive
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,IC50,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,3870.0,nM,=,CHEMBL4444043,active
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,IC50,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,17890.0,nM,=,CHEMBL4444093,inactive
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,IC50,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,15720.0,nM,=,CHEMBL4453548,inactive
Inhibition of beta amyloid in human SH-SY5Y cells,IC50,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,300000.0,nM,=,CHEMBL6246,inactive
Inhibition of beta amyloid (unknown origin) after 12 to 24 hrs,IC50,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,100000.0,nM,=,CHEMBL6246,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CCC1(C)C=Cc2c(O)cc(C)cc2O1,68000.0,nM,=,CHEMBL4645437,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)c(O)c1O,16700.0,nM,=,CHEMBL4640668,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC[C@@]1(C)C=Cc2c(cc(C)c(C(=O)O)c2O)O1,24700.0,nM,=,CHEMBL1171643,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CC/C=C(\C)CCCCCCCCC,62700.0,nM,=,CHEMBL2012313,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c1O,221000.0,nM,=,CHEMBL4643713,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,7400.0,nM,=,CHEMBL164,active
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1c(O)c(O)cc(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,29300.0,nM,=,CHEMBL4646459,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,150800.0,nM,=,CHEMBL4644047,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1c(O)c(O)c(-c2c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c2O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,12300.0,nM,=,CHEMBL4638539,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800.0,nM,=,CHEMBL487804,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300.0,nM,=,CHEMBL513978,inactive
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)cc1O,19900.0,nM,=,CHEMBL4641877,inactive
Inhibition of self-induced aggregation amyloid beta (1 to 42) (unknown origin) assessed as reduction in fibril formation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],12530.0,nM,=,CHEMBL4776150,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,3000.0,nM,=,CHEMBL4762873,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(Br)cc23)cc1,1100.0,nM,=,CHEMBL4796066,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OC(F)(F)F)cc23)cc1,3500.0,nM,=,CHEMBL4751082,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1,3000.0,nM,=,CHEMBL4761847,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,COc1cc2nc3ccccc3c(Nc3ccc(C(=O)NO)cc3)c2c(OC)c1OC,13000.0,nM,=,CHEMBL4753795,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)NO)cc3)c2n1,34900.0,nM,=,CHEMBL4750838,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,8500.0,nM,=,CHEMBL28626,active
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1,180.0,nM,=,CHEMBL81379,active
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,180.0,nM,=,CHEMBL986,active
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)CCCC1,180.0,nM,=,CHEMBL4787961,active
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,180.0,nM,=,CHEMBL38,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,19710.0,nM,=,CHEMBL4755968,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,2050.0,nM,=,CHEMBL4791642,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,15120.0,nM,=,CHEMBL4750451,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,18300.0,nM,=,CHEMBL4763981,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,13430.0,nM,=,CHEMBL165,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,16250.0,nM,=,CHEMBL140,inactive
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,IC50,O=c1cc(/C=C/c2nc3ccccc3o2)occ1O,7050.0,nM,=,CHEMBL4755924,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,IC50,O=c1cc(/C=C/c2nc3ccc(O)cc3s2)occ1O,5060.0,nM,=,CHEMBL4744947,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThT fluorescence assay,IC50,C#CCN(C)CCCn1ccc(=O)c(O)c1C,2850.0,nM,=,CHEMBL4740154,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2[nH]1,2160.0,nM,=,CHEMBL4874567,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,COc1ccc2[nH]c(C(=O)Nc3ccc4nc5n(c(=O)c4c3)CCC5)cc2c1,1210.0,nM,=,CHEMBL4861956,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(F)ccc2[nH]1,1560.0,nM,=,CHEMBL4854341,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(Cl)ccc2[nH]1,1690.0,nM,=,CHEMBL4871461,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2o1,3260.0,nM,=,CHEMBL4864253,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2s1,2300.0,nM,=,CHEMBL4871713,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Cc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,1620.0,nM,=,CHEMBL4878452,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,3090.0,nM,=,CHEMBL4853181,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(CCCc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,5270.0,nM,=,CHEMBL4870177,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,COc1ccc2[nH]c(C(=O)Nc3cc4c(=O)n5c(nc4cc3C)CCC5)cc2c1,6100.0,nM,=,CHEMBL4861631,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(F)ccc2[nH]1)CCC3,3270.0,nM,=,CHEMBL4856921,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(Cl)ccc2[nH]1)CCC3,5100.0,nM,=,CHEMBL4854859,active
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,9800.0,nM,=,CHEMBL497,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)O)ccc1O,226230.0,nM,=,CHEMBL32749,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N(C)C)ccc1OCc1ccccc1,24600.0,nM,=,CHEMBL4864402,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,39270.0,nM,=,CHEMBL4860315,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)CCc1ccc(OCc2ccccc2)c(OC)c1,34930.0,nM,=,CHEMBL4848839,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(O)c(O)c1,119160.0,nM,=,CHEMBL68672,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,12380.0,nM,=,CHEMBL4876981,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N(C)OC)ccc1OCc1ccccc1,79870.0,nM,=,CHEMBL4878181,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(F)(F)C2)ccc1OCc1ccccc1,106820.0,nM,=,CHEMBL4847323,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCCC2)ccc1OCc1ccccc1,65090.0,nM,=,CHEMBL4849442,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OCc1ccccc1,27940.0,nM,=,CHEMBL4862182,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3850.0,nM,=,CHEMBL140,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/CN2CCCCC2)ccc1OCc1ccccc1,10640.0,nM,=,CHEMBL4846673,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc([C@H]2C[C@@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,18650.0,nM,=,CHEMBL4873786,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc([C@H]2C[C@@H]2C(=O)N(C)C)ccc1OCc1ccccc1,45780.0,nM,=,CHEMBL4867164,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCOCC2)ccc1OCc1ccccc1,78070.0,nM,=,CHEMBL1511811,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,17080.0,nM,=,CHEMBL4846812,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,18720.0,nM,=,CHEMBL4878858,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,17750.0,nM,=,CHEMBL4868950,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,19240.0,nM,=,CHEMBL4856483,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,16830.0,nM,=,CHEMBL4877271,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,8590.0,nM,=,CHEMBL4877129,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)C1CN(C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)C1,12780.0,nM,=,CHEMBL4877193,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CC(F)(F)C3)C2)ccc1OCc1ccccc1,21830.0,nM,=,CHEMBL4876605,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCCCC3)C2)ccc1OCc1ccccc1,10550.0,nM,=,CHEMBL4868565,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCOCC3)C2)ccc1OCc1ccccc1,35670.0,nM,=,CHEMBL4874507,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccccc3)C2)ccc1OCc1ccccc1,3130.0,nM,=,CHEMBL4850421,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)N2CCCCC2)ccc1OCc1ccccc1,8170.0,nM,=,CHEMBL4872439,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)NCc2ccccc2)ccc1OCc1ccccc1,81560.0,nM,=,CHEMBL4869616,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccc(F)cc3)C2)ccc1OCc1ccccc1,3350.0,nM,=,CHEMBL4849121,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)C2CN(C(=O)/C=C/c3ccc(OCc4ccccc4)c(OC)c3)C2)cc1,4780.0,nM,=,CHEMBL4863966,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccco3)C2)ccc1OCc1ccccc1,3610.0,nM,=,CHEMBL4859895,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCCOc3ccccc3)C2)ccc1OCc1ccccc1,1800.0,nM,=,CHEMBL4863296,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)CCNC(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,54210.0,nM,=,CHEMBL4876813,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,17910.0,nM,=,CHEMBL4863014,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)Nc2nnn[nH]2)ccc1OCc1ccccc1,98460.0,nM,=,CHEMBL4846539,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(-c2cncn2CCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,7760.0,nM,=,CHEMBL4872213,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(-c2cncn2CCC(=O)NCCc2ccccc2)ccc1OCc1ccccc1,9910.0,nM,=,CHEMBL4845958,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(O)c(OC)c1,205460.0,nM,=,CHEMBL4458591,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OS(=O)(=O)c2ccc(C)cc2)c(OC)c1,10640.0,nM,=,CHEMBL4865997,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(O)c(OC)c1,98790.0,nM,=,CHEMBL4850411,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OC)c(OC)c1,45310.0,nM,=,CHEMBL4873939,inactive
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,2240.0,nM,=,CHEMBL4868743,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,3260.0,nM,=,CHEMBL4852639,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCOCC3)cc2)occ1O,4120.0,nM,=,CHEMBL4862604,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)co3)cc2)CC1,5540.0,nM,=,CHEMBL4876778,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,3950.0,nM,=,CHEMBL4857779,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,4510.0,nM,=,CHEMBL4848375,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cc1oc(/C=C/c2ccc(OCCCN3CCCC3)cc2)cc(=O)c1O,7010.0,nM,=,CHEMBL4870117,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cc1oc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)cc(=O)c1O,6260.0,nM,=,CHEMBL4859825,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,3290.0,nM,=,CHEMBL4856094,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,2570.0,nM,=,CHEMBL4846443,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCOCC2)cc1,5320.0,nM,=,CHEMBL4872910,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)cn3C)cc2)CC1,6020.0,nM,=,CHEMBL4848524,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,5380.0,nM,=,CHEMBL4853496,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,6180.0,nM,=,CHEMBL4852674,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,2070.0,nM,=,CHEMBL4876429,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,3050.0,nM,=,CHEMBL4878762,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7120.0,nM,=,CHEMBL4287929,active
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,8270.0,nM,=,CHEMBL140,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,3560.0,nM,=,CHEMBL4863690,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1480.0,nM,=,CHEMBL4873761,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1490.0,nM,=,CHEMBL4854597,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1270.0,nM,=,CHEMBL4861145,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,880.0,nM,=,CHEMBL4865817,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1030.0,nM,=,CHEMBL4876641,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1320.0,nM,=,CHEMBL4857021,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,2100.0,nM,=,CHEMBL4858987,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1380.0,nM,=,CHEMBL4874405,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,1680.0,nM,=,CHEMBL4854252,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3780.0,nM,=,CHEMBL4850978,active
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3170.0,nM,=,CHEMBL4872327,active
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 24 hrs by thioflavin-T fluorescence method,IC50,Cc1ccc(-n2cc(C(=O)Nc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,4600.0,nM,=,CHEMBL4878996,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,53010.0,nM,=,CHEMBL4850080,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CC(O)c1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,68500.0,nM,=,CHEMBL4860892,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,41160.0,nM,=,CHEMBL4879194,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,21920.0,nM,=,CHEMBL4861569,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CC(NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl)c1ccccc1,41150.0,nM,=,CHEMBL4871443,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,137390.0,nM,=,CHEMBL4877793,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CN(C)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,113130.0,nM,=,CHEMBL4846727,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CCCCCCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,47810.0,nM,=,CHEMBL4848103,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)Nc2ccccc2)c(Cl)cc1NCc1ccco1,167530.0,nM,=,CHEMBL4852897,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)NC2CCCCC2)c(Cl)cc1NCc1ccco1,115520.0,nM,=,CHEMBL4848555,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)O)c(NCC2CCCO2)cc1Cl,136390.0,nM,=,CHEMBL4867846,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(CO)c(NCc2ccco2)cc1Cl,117490.0,nM,=,CHEMBL4850077,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)OC)c(NCc2ccco2)cc1Cl,55950.0,nM,=,CHEMBL4851224,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(N)=O)c(NCc2ccco2)cc1Cl,82410.0,nM,=,CHEMBL4863425,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNC(=O)c1cc(S(=O)(=O)NC)c(Cl)cc1NCc1ccco1,102590.0,nM,=,CHEMBL4850840,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)N(C)C)c(NCc2ccco2)cc1Cl,6560.0,nM,=,CHEMBL4870723,active
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2ccco2)cc1Cl,70480.0,nM,=,CHEMBL4874275,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1ccc(F)cc1NCc1ccco1,129540.0,nM,=,CHEMBL4864237,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1ccc(Br)cc1NCc1ccco1,154420.0,nM,=,CHEMBL4858866,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,OC(c1ccc(F)cc1NCc1ccco1)C(F)(F)F,153050.0,nM,=,CHEMBL4858198,inactive
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,COc1ccc(C(O)C(F)(F)F)c(NCc2cscn2)c1,129690.0,nM,=,CHEMBL4848389,inactive
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3ccccc3O)ccc2nc2n1CCC2,4690.0,nM,=,CHEMBL4846102,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cccc(Br)c3O)ccc2nc2n1CCC2,8340.0,nM,=,CHEMBL4871074,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3ccc(Cl)cc3O)ccc2nc2n1CCC2,7020.0,nM,=,CHEMBL4876164,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1cccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c1O,4200.0,nM,=,CHEMBL4874834,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cc(Br)ccc3O)ccc2nc2n1CCC2,7630.0,nM,=,CHEMBL4871454,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cc(F)ccc3O)ccc2nc2n1CCC2,6300.0,nM,=,CHEMBL4861468,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1ccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c(O)c1,3910.0,nM,=,CHEMBL4852660,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1ccccc1O)CCC3,5090.0,nM,=,CHEMBL4849288,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cccc(Br)c1O)CCC3,9270.0,nM,=,CHEMBL4879281,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1ccc(Cl)cc1O)CCC3,6100.0,nM,=,CHEMBL4875354,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1cccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c1O,4260.0,nM,=,CHEMBL4870217,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(Br)ccc1O)CCC3,7370.0,nM,=,CHEMBL4853059,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(F)ccc1O)CCC3,6330.0,nM,=,CHEMBL4856085,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1ccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c(O)c1,3220.0,nM,=,CHEMBL4860689,active
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,9800.0,nM,=,CHEMBL497,active
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1c(O)c(O)c(C(=O)O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,6600.0,nM,=,CHEMBL4845912,active
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CCCC2=C/C(=C\C(C)(C)O)OC2=O)c1O,40700.0,nM,=,CHEMBL4847749,inactive
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CCCC1=C/C(=C\C(C)(C)O)OC1=O,51400.0,nM,=,CHEMBL4846858,inactive
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CC/C=C(\C)CC[C@H](O)C(C)(C)O,53300.0,nM,=,CHEMBL4871044,inactive
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800.0,nM,=,CHEMBL487804,inactive
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300.0,nM,=,CHEMBL513978,inactive
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COC(=O)c1c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c1O,50300.0,nM,=,CHEMBL4877566,inactive
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,9900.0,nM,=,CHEMBL164,active
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,IC50,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNc3c4c(nc5ccccc35)CCCC4)cccc21,1100.0,nM,=,CHEMBL4850546,active
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,IC50,CCN(C)C(=O)Oc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,1380.0,nM,=,CHEMBL4845823,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.3,nM,=,CHEMBL2152899,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2cc(C#N)nc2C(N)=N1,8.5,nM,=,CHEMBL5085521,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,12.6,nM,=,CHEMBL5088449,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.6,nM,=,CHEMBL5075933,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4c(C#N)cnc4C(N)=N3)c2)cn1,6.3,nM,=,CHEMBL5073381,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.0,nM,=,CHEMBL5084378,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.6,nM,=,CHEMBL5085412,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.0,nM,=,CHEMBL5093303,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,Cc1nc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)co1,4.8,nM,=,CHEMBL5093195,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.5,nM,=,CHEMBL5077699,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.2,nM,=,CHEMBL5082406,active
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)cn1,1.3,nM,=,CHEMBL5074068,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,98.0,nM,=,CHEMBL3261067,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)n1,3.0,nM,=,CHEMBL3261069,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1cc([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c(F)cn1,98.0,nM,=,CHEMBL3261068,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670365,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5.0,nM,=,CHEMBL3670368,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24.0,nM,=,CHEMBL3670371,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,10.0,nM,=,CHEMBL3670372,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,30.0,nM,=,CHEMBL5070669,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,26.0,nM,=,CHEMBL3670385,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,284.0,nM,=,CHEMBL3670367,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,263.0,nM,=,CHEMBL5089745,active
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,COCCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)n2)c(N)n1,23.0,nM,=,CHEMBL5080033,active
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta42 level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375,active
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta40 level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL3670375,active
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta(1 to 40 residues) level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375,active
Inhibition of APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CCSC(N)=N1,4.0,nM,=,CHEMBL5093426,active
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in soluble APP beta level incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,4.0,nM,=,CHEMBL3261067,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)COCC(N)=N1,17.0,nM,=,CHEMBL3653341,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,CC1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)COCC(N)=N1,3.0,nM,=,CHEMBL3653393,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@]1(C(F)(F)F)OC[C@@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)N=C1N,1160.0,nM,=,CHEMBL4128145,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@](C)(C(F)(F)F)C(N)=N1,32.0,nM,=,CHEMBL3653399,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5.0,nM,=,CHEMBL3653404,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24.0,nM,=,CHEMBL3653403,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9.0,nM,=,CHEMBL3653405,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1nc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,105.0,nM,=,CHEMBL5077684,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL5073160,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL5090563,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)c2)c(C)c1,17.0,nM,=,CHEMBL5075177,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,6.0,nM,=,CHEMBL5086270,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9.0,nM,=,CHEMBL5074449,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL5085959,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL3653401,active
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL3653401,active
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 40 secretion incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067,active
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 42 secretion incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067,active
